Status:
RECRUITING
Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy
Lead Sponsor:
Karolinska Institutet
Conditions:
Panic Disorder
Generalized Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary aim of the pilot study is to investigate the feasibility of conducting a randomized controlled trial (RCT) comparing the effects of transdiagnostic and diagnosis-specific cognitive-behavio...
Detailed Description
Aim The primary aim of the pilot study is to investigate the feasibility of conducting an RCT comparing the the effects of two types of protocol-based individual CBT for patients with anxiety disorde...
Eligibility Criteria
Inclusion
- 18-65 years of age,
- Being able to speak Swedish without interpreter support,
- A principal diagnosis of panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, or posttraumatic stress disorder, and
- Pharmacological treatment (if any) that is stable six weeks prior to treatment start
Exclusion
- Current diagnosis of psychotic disorder, bipolar disorder, or moderate to severe substance use disorder,
- Moderate to severe risk of suicide,
- Psychiatric, somatic, or social problems which require other management or intervention than cognitive-behavioral therapy, and
- Other simultaneous psychological treatment
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT05249543
Start Date
March 1 2022
End Date
September 1 2025
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WeMind
Stockholm, Sweden, 11357